Global Information
회사소개 | 문의 | 비교리스트

세계의 말초혈액 단핵세포(PBMC) 시장 : 예측과 기회(-2025년)

Global Peripheral Blood Mononuclear Cells Market By Product, By Application, By Technique, By Source, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 938728
페이지 정보 영문 117 Pages
가격
US $ 4,450 ₩ 5,070,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,209,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,767,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 말초혈액 단핵세포(PBMC) 시장 : 예측과 기회(-2025년) Global Peripheral Blood Mononuclear Cells Market By Product, By Application, By Technique, By Source, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 117 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 말초혈액 단핵세포(PBMC) 시장은 예측기간 중 안정된 CAGR로 성장할 것으로 예상됩니다. 말초혈액 단핵세포는 생물학 및 병리학 관련 연구와 암 관련 임상 연구를 실시하기 위해 중요합니다. 또한 PBMC는 치명적인 질환, 면역학, 백신 개발 등과 관련된 연구에도 이용되고 있습니다.

세계의 말초혈액 단핵세포(PBMC : Peripheral Blood Mononuclear Cells) 시장을 부문별 및 지역별로 조사했으며, 시장 규모 및 시장 점유율 예측, 성장 촉진요인과 과제, 시장 동향, 경쟁 상황, 기업 개요 등의 정보를 제공합니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 말초혈액 단핵세포 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품별(동결보존 또는 냉동, 배양 또는 신선, 말초혈액 단핵세포 분리·생존 키트)
    • 용도별(면역학적 검사, 감염증, 혈액학적 검사, 기타)
    • 기술별(밀도구배원심분리 프로세스, 백혈구성분채집술)
    • 소스별(인간, 동물)
    • 기업별(2019년)
    • 지역별
  • 시장 매력 지수

제6장 아시아태평양의 말초혈액 단핵세포 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 기술별
    • 소스별
    • 국가별
  • 시장 매력 지수
  • 아시아태평양 : 국가 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 싱가포르
    • 호주

제7장 유럽의 말초혈액 단핵세포 시장 전망

  • 시장 규모와 예측
  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 기술별
    • 소스별
    • 국가별
  • 시장 매력 지수
  • 유럽 : 국가 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아

제8장 북미의 말초혈액 단핵세포 시장 전망

  • 시장 규모와 예측
  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 기술별
    • 소스별
    • 국가별
  • 시장 매력 지수
  • 북미 : 국가 분석
    • 미국
    • 멕시코
    • 캐나다

제9장 남미의 말초혈액 단핵세포 시장 전망

  • 시장 규모와 예측
  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 기술별
    • 소스별
    • 국가별
  • 시장 매력 지수
  • 남미 : 국가 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 말초혈액 단핵세포 시장 전망

  • 시장 규모와 예측
  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품별
    • 용도별
    • 기술별
    • 소스별
    • 국가별
  • 시장 매력 지수
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국
    • 사우디아라비아
    • UAE

제11장 시장 역학

  • 성장 촉진요인
  • 성장 억제요인

제12장 시장 동향과 발전

제13장 임상시험

제14장 경쟁 상황

  • 경쟁 예측
  • 주요 기업 개요
    • Astarte Biologics, Inc.
    • ATZLabs
    • BioIVT
    • BioLegend, Inc.
    • BioVision
    • Bio-Rad
    • Cell Applications, Inc
    • Celgene
    • Creative Bioarray
    • Dapcel, Inc
    • HemaCare
    • iXCells Biotechnologies
    • Miltenyi Biotec
    • Merck
    • Novo Nordisk
    • Precision Medicine
    • Qiagen NV
    • STEMCELL Technologies Inc.
    • Thermo Fisher Scientific
    • ZenBio, Inc

제15장 전략적 추천

제16장 면책사항

KSM 20.06.11

The global market for peripheral blood mononuclear cells is expected to grow at a steady CAGR during the forecast period. The peripheral blood mononuclear cells (PBMCs) are crucial to carry out the biology and pathology related studies as well as in clinical research related to cancer. Besides, PBMCs are also utilized in research related to fatal diseases, immunology, vaccine development, etc. However, high cost of PBMCs related studies might act as a challenge for the adoption of technology by developing economies.

The global peripheral blood mononuclear cells market is segmented based on product, application, technique, source, company and region. The product segment is further divided into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits. As of 2019, the cryopreserved PBMC or the frozen PBMC segment held the highest market share as they can be used for longer durations of time if stored carefully at lower temperatures.

In terms of regional analysis, North America accounted for the largest market share in the year 2019, on the back of a number of pre-existing peripheral blood mononuclear cells-based companies in the region. The economy of the region is also rich enough, which makes it easier to carry out the complex and costly R&D procedures.

Major players of the global peripheral blood mononuclear cells market include Astarte Biologics, Inc., ATZLabs, BioIVT, BioLegend, Inc., BioVision, Bio-Rad, Cell Applications, Inc., Celgene, Creative Bioarray, Dapcel, Inc, HemaCare, iXCells Biotechnologies, Miltenyi Biotec, Merck, Novo Nordisk, Precision Medicine, Qiagen NV, STEMCELL Technologies Inc., Thermo Fisher Scientific, ZenBio, Inc., etc. The inter-company competition keeps on increasing parallelly with the market, which in turn leads to innovations in technology, which eventually leading to the growth of the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of global peripheral blood mononuclear cells market.
  • To classify and forecast global peripheral blood mononuclear cells market based on product, application, technique, source, company and region.
  • To identify drivers and challenges for global peripheral blood mononuclear cells market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global peripheral blood mononuclear cells market.
  • To conduct pricing analysis for global peripheral blood mononuclear cells market.
  • To identify and analyze the profile of leading players operating in global peripheral blood mononuclear cells market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of research organizations and companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the research organizations and companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the research organizations and companies, and presence of all major players across the globe.

TechSci Research calculated the market size of global peripheral blood mononuclear cells market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Research Organizations
  • Biotechnology and pharma companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to peripheral blood mononuclear cells
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research organizations & companies and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global peripheral blood mononuclear cells market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product:

Cryopreserved or Frozen PBMC

Cultured or Fresh PBMC

Peripheral Blood Mononuclear Cell Isolation & Viability Kits

  • Market, By Application:

Immunology

Infectious disease

Hematology

Others

  • Market, By Technique:

Density gradient centrifugation process

Leukapheresis

  • Market, By Source:

Human

Animals

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle east & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Peripheral Blood Mononuclear Cells Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
    • 5.2.2. By Application (Immunology, Infectious disease, Hematology and others)
    • 5.2.3. By Technique (Density gradient centrifugation process, Leukapheresis)
    • 5.2.4. By Source (Human, Animals)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Technique
    • 6.2.4. By Source
    • 6.2.5. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Product
        • 6.4.1.2.2. By Application
        • 6.4.1.2.3. By Technique
        • 6.4.1.2.4. By Source
    • 6.4.2. India Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Product
        • 6.4.2.2.2. By Application
        • 6.4.2.2.3. By Technique
        • 6.4.2.2.4. By Source
    • 6.4.3. Japan Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Product
        • 6.4.3.2.2. By Application
        • 6.4.3.2.3. By Technique
        • 6.4.3.2.4. By Source
    • 6.4.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Product
        • 6.4.4.2.2. By Application
        • 6.4.4.2.3. By Technique
        • 6.4.4.2.4. By Source
    • 6.4.5. Singapore Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Product
        • 6.4.5.2.2. By Application
        • 6.4.5.2.3. By Technique
        • 6.4.5.2.4. By Source
    • 6.4.6. Australia Peripheral Blood Mononuclear Cells Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Product
        • 6.4.6.2.2. By Application
        • 6.4.6.2.3. By Technique
        • 6.4.6.2.4. By Source

7. Europe Peripheral Blood Mononuclear Cells Market Outlook

  • 7.1. Market Size & Forecast
  • 7.2. Market Size & Forecast
    • 7.2.1. By Value
  • 7.3. Market Share & Forecast
    • 7.3.1. By Product
    • 7.3.2. By Application
    • 7.3.3. By Technique
    • 7.3.4. By Source
    • 7.3.5. By Country
  • 7.4. Market Attractiveness Index
  • 7.5. Europe: Country Analysis
    • 7.5.1. France Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.1.1. Market Size & Forecast
        • 7.5.1.1.1. By Value
      • 7.5.1.2. Market Share & Forecast
        • 7.5.1.2.1. By Product
        • 7.5.1.2.2. By Application
        • 7.5.1.2.3. By Technique
        • 7.5.1.2.4. By Source
    • 7.5.2. Germany Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.2.1. Market Size & Forecast
        • 7.5.2.1.1. By Value
      • 7.5.2.2. Market Share & Forecast
        • 7.5.2.2.1. By Product
        • 7.5.2.2.2. By Application
        • 7.5.2.2.3. By Technique
        • 7.5.2.2.4. By Source
    • 7.5.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.3.1. Market Size & Forecast
        • 7.5.3.1.1. By Value
      • 7.5.3.2. Market Share & Forecast
        • 7.5.3.2.1. By Product
        • 7.5.3.2.2. By Application
        • 7.5.3.2.3. By Technique
        • 7.5.3.2.4. By Source
    • 7.5.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
      • 7.5.4.1. Market Size & Forecast
        • 7.5.4.1.1. By Value
      • 7.5.4.2. Market Share & Forecast
        • 7.5.4.2.1. By Product
        • 7.5.4.2.2. By Application
        • 7.5.4.2.3. By Technique
        • 7.5.4.2.4. By Source

8. North America Peripheral Blood Mononuclear Cells Market Outlook

  • 8.1. Market Size & Forecast
  • 8.2. Market Size & Forecast
    • 8.2.1. By Value
  • 8.3. Market Share & Forecast
    • 8.3.1. By Product
    • 8.3.2. By Application
    • 8.3.3. By Technique
    • 8.3.4. By Source
    • 8.3.5. By Country
  • 8.4. Market Attractiveness Index
  • 8.5. North America: Country Analysis
    • 8.5.1. United States Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.1.1. Market Size & Forecast
        • 8.5.1.1.1. By Value
      • 8.5.1.2. Market Share & Forecast
        • 8.5.1.2.1. By Product
        • 8.5.1.2.2. By Application
        • 8.5.1.2.3. By Technique
        • 8.5.1.2.4. By Source
    • 8.5.2. Mexico Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.2.1. Market Size & Forecast
        • 8.5.2.1.1. By Value
      • 8.5.2.2. Market Share & Forecast
        • 8.5.2.2.1. By Product
        • 8.5.2.2.2. By Application
        • 8.5.2.2.3. By Technique
        • 8.5.2.2.4. By Source
    • 8.5.3. Canada Peripheral Blood Mononuclear Cells Market Outlook
      • 8.5.3.1. Market Size & Forecast
        • 8.5.3.1.1. By Value
      • 8.5.3.2. Market Share & Forecast
        • 8.5.3.2.1. By Product
        • 8.5.3.2.2. By Application
        • 8.5.3.2.3. By Technique
        • 8.5.3.2.4. By Source

9. South America Peripheral Blood Mononuclear Cells Market Outlook

  • 9.1. Market Size & Forecast
  • 9.2. Market Size & Forecast
    • 9.2.1. By Value
  • 9.3. Market Share & Forecast
    • 9.3.1. By Product
    • 9.3.2. By Application
    • 9.3.3. By Technique
    • 9.3.4. By Source
    • 9.3.5. By Country
  • 9.4. Market Attractiveness Index
  • 9.5. South America: Country Analysis
    • 9.5.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.1.1. Market Size & Forecast
        • 9.5.1.1.1. By Value
      • 9.5.1.2. Market Share & Forecast
        • 9.5.1.2.1. By Product
        • 9.5.1.2.2. By Application
        • 9.5.1.2.3. By Technique
        • 9.5.1.2.4. By Source
    • 9.5.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.2.1. Market Size & Forecast
        • 9.5.2.1.1. By Value
      • 9.5.2.2. Market Share & Forecast
        • 9.5.2.2.1. By Product
        • 9.5.2.2.2. By Application
        • 9.5.2.2.3. By Technique
        • 9.5.2.2.4. By Source
    • 9.5.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
      • 9.5.3.1. Market Size & Forecast
        • 9.5.3.1.1. By Value
      • 9.5.3.2. Market Share & Forecast
        • 9.5.3.2.1. By Product
        • 9.5.3.2.2. By Application
        • 9.5.3.2.3. By Technique
        • 9.5.3.2.4. By Source

10. Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook

  • 10.1. Market Size & Forecast
  • 10.2. Market Size & Forecast
    • 10.2.1. By Value
  • 10.3. Market Share & Forecast
    • 10.3.1. By Product
    • 10.3.2. By Application
    • 10.3.3. By Technique
    • 10.3.4. By Source
    • 10.3.5. By Country
  • 10.4. Market Attractiveness Index
  • 10.5. MEA: Country Analysis
    • 10.5.1. South Africa Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.1.1. Market Size & Forecast
        • 10.5.1.1.1. By Value
      • 10.5.1.2. Market Share & Forecast
        • 10.5.1.2.1. By Product
        • 10.5.1.2.2. By Application
        • 10.5.1.2.3. By Technique
        • 10.5.1.2.4. By Source
    • 10.5.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.2.1. Market Size & Forecast
        • 10.5.2.1.1. By Value
      • 10.5.2.2. Market Share & Forecast
        • 10.5.2.2.1. By Product
        • 10.5.2.2.2. By Application
        • 10.5.2.2.3. By Technique
        • 10.5.2.2.4. By Source
    • 10.5.3. UAE Peripheral Blood Mononuclear Cells Market Outlook
      • 10.5.3.1. Market Size & Forecast
        • 10.5.3.1.1. By Value
      • 10.5.3.2. Market Share & Forecast
        • 10.5.3.2.1. By Product
        • 10.5.3.2.2. By Application
        • 10.5.3.2.3. By Technique
        • 10.5.3.2.4. By Source

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Clinical Trials

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Astarte Biologics, Inc.
    • 14.2.2. ATZLabs
    • 14.2.3. BioIVT
    • 14.2.4. BioLegend, Inc.
    • 14.2.5. BioVision
    • 14.2.6. Bio-Rad
    • 14.2.7. Cell Applications, Inc
    • 14.2.8. Celgene
    • 14.2.9. Creative Bioarray
    • 14.2.10. Dapcel, Inc
    • 14.2.11. HemaCare
    • 14.2.12. iXCells Biotechnologies
    • 14.2.13. Miltenyi Biotec
    • 14.2.14. Merck
    • 14.2.15. Novo Nordisk
    • 14.2.16. Precision Medicine
    • 14.2.17. Qiagen NV
    • 14.2.18. STEMCELL Technologies Inc.
    • 14.2.19. Thermo Fisher Scientific
    • 14.2.20. ZenBio, Inc

15. Strategic Recommendation

16. About Us & Disclaimer

Back to Top
전화 문의
F A Q